Literature DB >> 28573387

The impact of change of renal replacement therapy modality on sleep quality in patients with end-stage renal disease: a systematic review and meta-analysis.

C Kennedy1,2, S A Ryan3, T Kane4, R W Costello5,4, P J Conlon5,6.   

Abstract

BACKGROUND: Sleep disorders are common and multi-factorial in patients with advanced chronic kidney disease and end-stage renal disease (ESRD). Sleep disorders and disturbance have a negative impact on wellbeing and quality of life.
OBJECTIVE: To assess the impact of a change in renal replacement therapy (RRT) modality on sleep quality and sleep disturbance in patients with ESRD. DATA SOURCES: Multiple electronic databases were searched without publication type/period restrictions. The reference lists of all included articles were manually searched for additional citations. Non-published data was identified by hand searching key conference abstracts. STUDY ELIGIBILITY CRITERIA: Participants of interest were adult patients with ESRD requiring RRT [conventional haemodialysis (HD), short daily HD, nocturnal HD, continuous ambulatory peritoneal dialysis (CAPD), continuous cycler-assisted peritoneal dialysis (CCPD) or transplantation]. The exposure or intervention of interest was switch of RRT modality. STUDY APPRAISAL: Two reviewers independently assessed all studies for inclusion and extracted relevant data.
RESULTS: Sixteen studies with a combined total of 670 patients and 191 controls were included for review and described in detail. Looking specifically at restless leg syndrome, symptoms resolved in over 60% of affected patients with a switch to increased intensity RRT (either intensive HD, CCPD or transplant). Meta-analysis of the nine studies that looked specifically at sleep apnoea parameters again favoured intensive RRT over standard/conventional RRT (conventional HD or CAPD) with statistical significance [Risk ratio 0.66 (95% CI 0.51-0.84)]. Meta-analysis of all studies favoured a switch to increased intensity RRT in terms of overall sleep quality, with statistical significance [Risk ratio 0.58 (95% CI 0.40-8.83)]. LIMITATIONS: Restriction to the English language may have introduced selection bias. Funnel plot analysis suggested there was also an element of publication bias. Studies were heterogeneous in terms of patient selection, means of sleep quality assessment and modality switch. CONCLUSIONS AND IMPLICATIONS OF KEY
FINDINGS: Sleep disturbance, sleep apnoea and restless legs syndrome all tend to improve when a switch is made to intensive dialysis or transplant. This is important information for patients struggling with disturbed sleep and marked fatigue. This hypothesis-generating review highlights the need for more high quality prospective research in the area.

Entities:  

Keywords:  Dialysis modality; Renal replacement therapy; Restless leg syndrome; Sleep apnoea; Sleep disorders; Transplant

Mesh:

Year:  2017        PMID: 28573387     DOI: 10.1007/s40620-017-0409-7

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  36 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Int J Surg       Date:  2010-02-18       Impact factor: 6.071

2.  Alleviation of sleep apnea in patients with chronic renal failure by nocturnal cycler-assisted peritoneal dialysis compared with conventional continuous ambulatory peritoneal dialysis.

Authors:  Sydney C W Tang; Bing Lam; Pui Pui Ku; Wah Shing Leung; Chung Ming Chu; Yiu Wing Ho; Mary S M Ip; Kar Neng Lai
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

3.  Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease.

Authors:  Jaime M Beecroft; Victor Hoffstein; Andreas Pierratos; Christopher T Chan; Philip McFarlane; Patrick J Hanly
Journal:  Nephrol Dial Transplant       Date:  2007-09-22       Impact factor: 5.992

4.  Sleep disordered breathing in renal transplant patients.

Authors:  F Mallamaci; D Leonardis; R Tripepi; G Parlongo; C Catalano; G Tripepi; V Castronovo; L Ferini-Strambi; C Zoccali
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

5.  Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis.

Authors:  Patrick J Hanly; Jonathan Y Gabor; Chris Chan; Andreas Pierratos
Journal:  Am J Kidney Dis       Date:  2003-02       Impact factor: 8.860

6.  Subjective and objective sleep quality in patients on conventional thrice-weekly hemodialysis: comparison with matched controls from the sleep heart health study.

Authors:  Mark L Unruh; Mark H Sanders; Susan Redline; Beth M Piraino; Jason G Umans; Hassan Chami; Rohit Budhiraja; Naresh M Punjabi; Daniel Buysse; Anne B Newman
Journal:  Am J Kidney Dis       Date:  2008-07-09       Impact factor: 8.860

7.  Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep.

Authors:  Christopher T Chan; Pat Hanly; Jonathan Gabor; Peter Picton; Andreas Pierratos; John S Floras
Journal:  Kidney Int       Date:  2004-02       Impact factor: 10.612

8.  Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance.

Authors:  Sydney C W Tang; Bing Lam; Andrew S H Lai; Clara B Y Pang; Wai Kuen Tso; Pek Lan Khong; Mary S M Ip; Kar Neng Lai
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

9.  Improvement of sleep-related breathing disorder in patients with end-stage renal disease after kidney transplantation.

Authors:  Jeong Jin Lee; Gaab Soo Kim; Jie Ae Kim; Sung-Joo Kim; Jin Gu Kang; Gunn Hee Kim; Hae Hyuk Jung
Journal:  Clin Transplant       Date:  2011 Jan-Feb       Impact factor: 2.863

10.  Patient Perspectives on the Choice of Dialysis Modality: Results From the Empowering Patients on Choices for Renal Replacement Therapy (EPOCH-RRT) Study.

Authors:  Claudia Dahlerus; Martha Quinn; Emily Messersmith; Laurie Lachance; Lalita Subramanian; Erica Perry; Jill Cole; Junhui Zhao; Celeste Lee; Margie McCall; Leslie Paulson; Francesca Tentori
Journal:  Am J Kidney Dis       Date:  2016-06-21       Impact factor: 8.860

View more
  4 in total

Review 1.  A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD.

Authors:  Maureen Metzger; Emaad M Abdel-Rahman; Heather Boykin; Mi-Kyung Song
Journal:  Kidney Int Rep       Date:  2021-02-10

2.  Associations of Chronic Kidney Disease With Dementia Before and After TIA and Stroke: Population-Based Cohort Study.

Authors:  Dearbhla M Kelly; Sarah T Pendlebury; Peter M Rothwell
Journal:  Neurology       Date:  2022-01-07       Impact factor: 9.910

Review 3.  Mechanisms of cognitive dysfunction in CKD.

Authors:  Davide Viggiano; Carsten A Wagner; Gianvito Martino; Maiken Nedergaard; Carmine Zoccali; Robert Unwin; Giovambattista Capasso
Journal:  Nat Rev Nephrol       Date:  2020-03-31       Impact factor: 28.314

4.  Effect of nocturnal hemodialysis on sleep parameters in patients with end-stage renal disease: a systematic review and meta-analysis.

Authors:  Lingzhi Li; Xi Tang; Sehee Kim; Ye Zhang; Yi Li; Ping Fu
Journal:  PLoS One       Date:  2018-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.